Light Chain Bioscience | Novimmune SA

Light Chain Bioscience | Novimmune SA

Biotechnology Research Ch 80 employees
Employees
80
Contacts
2
Emails
2

Light Chain Bioscience | Novimmune SA Overview

Headquarters
Ch
Phone Number
Available in AeroLeads
Website
novimmune.com
Industry
Biotechnology Research
Employees
80
Founded
1998
Funding
29.8M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Light Chain Bioscience | Novimmune SA

NovImmune has successfully divested EmaCo AG, a newly established company owning emapalumab and related assets to Sobi on 18 July 2019. NovImmune SA will continue to operate and focus on its bispecific technology and associated programs and will rebrand as: “Light Chain Bioscience – A brand of Novimmune SA”. The brand Light Chain Bioscience brings to life the research and development of novel multi-specific antibodies that rely on their light chain for their function. A key distinctive feature of these multispecific antibodies is their native human structure, making them well tolerated and easy to develop. Thus far, NovImmune has advanced seven drug candidates to treat a range of conditions. The Company’s pipeline is a balance of preclinical and clinical candidates for validated and novel targets. NovImmune has established a next-generation antibody drug discovery platform that includes novel bispecific antibody drug capabilities - the simple, stable and smart kappa-lambda-body™. In 2009, NovImmune received the European Biotechnica Award. In 2010, NovImmune entered a partnership with Genentech to advance the Company’s anti-IL17 drug candidate. In addition to pursuing additional drug discovery, development and commercialization partnerships, the Company plans to bring selected drugs to market for focused applications.

Light Chain Bioscience | Novimmune SA Contact Details

People in AeroLeads
3
With contact data
2
Email contacts
2
66.7% coverage

Light Chain Bioscience | Novimmune SA Org Chart

Sample employees and titles
Name Title Contact
Limin Shang Director of Pharmacology at Light Chain Bioscience
Email
Oliver Eckelmann, Ph.d. Entrepreneur, Ceo/coo/cfo Executive & Board Member - Strategy & Leadership for Fast-track Biotech/pharma Start-up & Success
View
Walter Ferlin Chief Scientific Officer at Light Chain Bioscience
Email

Employees by Management Level

Senior / Lead 3 profiles
Individual contributor 3 profiles
Executive 2 profiles
Director 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 3 3 0

Light Chain Bioscience | Novimmune SA Tech Stack

Cloud / infrastructure 1 profile

Compare Similar Companies to Light Chain Bioscience | Novimmune SA